outgoing Infinity Pharmaceuticals CEO Adelene Perkins and CMO Robert Ilaria
September 5, 2023 05:32 AM EDTUpdated 06:05 AM
People

Fall­out from failed MEI merg­er con­tin­ues as In­fin­i­ty's CEO, CMO ex­it

Reynald Castañeda

Deputy Editor

In­fin­i­ty Phar­ma­ceu­ti­cals CEO Ade­lene Perkins and CMO Robert Ilar­ia were ter­mi­nat­ed “with­out cause” from their roles on Sept. 1 as a part of the com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times